PCML
WVE icon

Pavaki Capital Management LLC’s Wave Life Sciences WVE Stock Holding History

Pavaki Capital Management LLC’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.2K Hold
15,000
– – 0.03% 159
2026
Q1 		$109K Buy
+15,000
New +$195K 0.05% 148

Other funds holding WVE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Pavaki Capital Management LLC's WVE Position: Q2 2026 in Review

Pavaki Capital Management LLC held its Wave Life Sciences (WVE) position steady in Q2 2026 at 15,000 shares worth $87.2K. The position accounts for 0.03% of the portfolio, ranked #159.

Pavaki Capital Management LLC first reported a position in WVE in Q1 2026 and has held it in 2 quarters since. The position peaked at $109K in Q1 2026. 80 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Pavaki Capital Management LLC held 15,000 shares of Wave Life Sciences worth $87.2K as of Q2 2026.
  • Pavaki Capital Management LLC left its Wave Life Sciences share count unchanged in Q2 2026.
  • Wave Life Sciences made up 0.03% of Pavaki Capital Management LLC's portfolio in Q2 2026, its #159 holding.
  • Pavaki Capital Management LLC first reported a position in Wave Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Pavaki Capital Management LLC's Wave Life Sciences position peaked at $109K in Q1 2026.
  • 80 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Pavaki Capital Management LLC's 13F filing for Q2 2026, filed 7 Aug 2026.